DAMA VANCE: Open Payments
NPI 1447470349 · ROMNEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 50 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $854 · 2025 $986
Food & beverage: $887Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $242 |
| ABBVIE INC. | 10 | $171 |
| UCB, Inc. | 4 | $161 |
| Organogenesis Inc. | 10 | $153 |
| Galderma Laboratories, L.P. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $69 |
| Lilly USA, LLC | 3 | $51 |
| LEO Pharma Inc. | 1 | $26 |
| Amgen Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: TREMFYA, Bimzelx, RINVOQ, NEMLUVIO, COSENTYX, TALTZ, NUSHIELD, CYGNUS DUAL.
Industry payments across WV — which companies pay providers there.
